Conexiant has partnered with Elsevier to deliver world-class solutions and sales execution to more than 100 global societies and associations covering more than 25 core specialties in the health-care space. This collaboration marks a significant step forward in delivering innovative advertising, content solutions, and advanced audience-targeting capabilities to medical associations, publishers, and health-care professionals worldwide.
Through this strategic partnership, Conexiant will manage not only print and digital advertising sales, sponsored content, and classified listings but also the implementation and delivery of enhanced digital solutions (including programmatic advertising, triggered marketing campaigns, clinical content programs, and customized engagement solutions). These offerings will allow societies and advertisers to leverage advanced marketing and digital solutions to develop meaningful and integrated media strategies.
“I’m thrilled to enter into this strategic alliance with Elsevier, a global leader in clinical research and publishing. By combining our expertise, we can empower Elsevier’s society partners to embrace innovative strategies, launch cutting-edge products, and adopt emerging technologies. Our shared vision is to deliver meaningful member benefits that drive advancements in health care and ultimately improve patient outcomes,” stated Charlie Lee, Chief Executive Officer of Conexiant.
Charlie Lee
As Conexiant embarks on this exciting new partnership, the company remains committed to supporting medical societies with cutting-edge advertising solutions and operational excellence. The partnership is set to launch on April 1, 2025, with additional solutions rolling out later this year, including expanded digital products, video engagement tools, content syndication services, and data-driven targeting solutions.
Conexiant publishes The ASCO Post under a license agreement with ASCO.
